Similarly, by spatial transcriptomics, FGF19+ spots were overrepresented in the embryonal clusters in both HB4 and HB17, accounting for ~7-8% of the embryonal cluster while representing only ~2% of the tumor as a whole (Fig. 2b-c, Supplementary Fig. S2c-e). This evidence concerns the gene FGF19 and neoplasm.